Large-scale testing (Phase 3)Study completedNCT00981838
What this trial is testing
Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)
Who this might be right for
Nephrotic Syndrome
Mario Negri Institute for Pharmacological Research 24